APA

Smith II J. W., Kurt R. A., Baher A. G., Denman S., Justice L., Doran T., Gilbert M., Alvord W. G. & Urba W. J. (20030926). Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Chicago

Smith II John W, Kurt Robert A, Baher Angelo G, Denman Susan, Justice Lisa, Doran Teri, Gilbert Mark, Alvord W Gregory and Urba Walter J. 20030926. Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Harvard

Smith II J. W., Kurt R. A., Baher A. G., Denman S., Justice L., Doran T., Gilbert M., Alvord W. G. and Urba W. J. (20030926). Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma. : Journal of immunotherapy (Hagerstown, Md. : 1997).

MLA

Smith II John W, Kurt Robert A, Baher Angelo G, Denman Susan, Justice Lisa, Doran Teri, Gilbert Mark, Alvord W Gregory and Urba Walter J. Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma. : Journal of immunotherapy (Hagerstown, Md. : 1997). 20030926.